FPR1 and leukemia: As expected, TL and SKF treatments significantly blunted the kinetics of the fMLP-evoked fast and sustained rise in [Ca2+]i in all leukemia cell lines due to inhibition of fMLP-induced stimulation of TRPV2 Ca2+ activity.